Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
Clinical trial NCT04001231 · WITHDRAWN
Trial details
- NCT number
- NCT04001231
- Sponsor
- AstraZeneca
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-07-02
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.